Biotechnology Contract Manufacturing Market Size, Share, and Outlook, H2-2025 Report- By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufactur
Description
Biotechnology Contract Manufacturing Market Outlook
The global Biotechnology Contract Manufacturing Market Size is valued at $24.8 Billion in 2025 and is forecast to reach $45 Billion in 2032 at a CAGR of 8.9%.
The Biotechnology Contract Manufacturing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Biotechnology Contract Manufacturing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale of Operation (Commercial Operations, Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Biotechnology Contract Manufacturing Market Insights, 2025
The biotechnology contract manufacturing market is growing robustly as biopharmaceutical companies outsource production to specialized contract manufacturing organizations (CMOs) to reduce costs and accelerate time-to-market. Recent trends include expanded single-use facility capabilities, modular manufacturing units, and flexible process platforms that accommodate diverse biologic modalities including mAbs, vaccines, and cell therapies. CMOs are investing in automation, digitalization, and advanced analytics to improve quality and compliance. Strategic partnerships and capacity expansions in emerging biotech hubs globally address rising demand. Regulatory requirements for quality assurance and supply chain integrity drive continuous process improvements. The market benefits from increasing complexity of biologic pipelines and the growing trend of biopharma virtual companies relying on outsourcing.
Five Trends Shaping the Global Biotechnology Contract Manufacturing Market in 2025 and Beyond
The global Biotechnology Contract Manufacturing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Biotechnology Contract Manufacturing Industry?
The Biotechnology Contract Manufacturing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Biotechnology Contract Manufacturing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Biotechnology Contract Manufacturing Market Segment Insights
The Biotechnology Contract Manufacturing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale of Operation (Commercial Operations, Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Biotechnology Contract Manufacturing Industry Value Chain
The chapter identifies potential companies and their operations across the global Biotechnology Contract Manufacturing Industry ecosystem. It assists decision-makers in evaluating global Biotechnology Contract Manufacturing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Biotechnology Contract Manufacturing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Biotechnology Contract Manufacturing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Biotechnology Contract Manufacturing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Biotechnology Contract Manufacturing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Biotechnology Contract Manufacturing Market.
Europe Biotechnology Contract Manufacturing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Biotechnology Contract Manufacturing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Biotechnology Contract Manufacturing Industry competitiveness. The report analyses the key Biotechnology Contract Manufacturing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Biotechnology Contract Manufacturing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Biotechnology Contract Manufacturing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Biotechnology Contract Manufacturing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Biotechnology Contract Manufacturing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Biotechnology Contract Manufacturing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Biotechnology Contract Manufacturing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AbbVie Inc, AGC Inc, Boehringer Ingelheim International GmbH, Catalent Inc, Eurofins Scientific SE, FUJIFILM Holdings Corp, GenScript Biotech Corp, JSR Corp, Lonza Group Ltd, Merck KgaA, Samsung Biologics Co. Ltd, Thermo Fisher Scientific Inc, WuXi Biologics Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Biotechnology Contract Manufacturing Market Scope
Leading Segments
By Service
Manufacturing
Formulation and Fill-Finish
Packaging and Labeling
Others
By Type
Biologic Drug Substance Manufacturing
Biologic Drug Product Manufacturing
By Scale of Operation
Commercial Operations
Clinical Operations
By Source
Mammalian Expression Systems
Non-Mammalian Expression Systems
By Molecule
Monoclonal Antibodies
Cell Therapy & Gene Therapy
Antibody-Drug Conjugates (ADCs)
Vaccines
Therapeutic Peptides & Proteins
Others
By Indication
Oncology
Autoimmune Diseases
Cardiovascular Diseases
Metabolic Diseases
Infectious Diseases
Neurology
Others
Leading Companies
AbbVie Inc
AGC Inc
Boehringer Ingelheim International GmbH
Catalent Inc
Eurofins Scientific SE
FUJIFILM Holdings Corp
GenScript Biotech Corp
JSR Corp
Lonza Group Ltd
Merck KgaA
Samsung Biologics Co. Ltd
Thermo Fisher Scientific Inc
WuXi Biologics Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Biotechnology Contract Manufacturing Market Size is valued at $24.8 Billion in 2025 and is forecast to reach $45 Billion in 2032 at a CAGR of 8.9%.
The Biotechnology Contract Manufacturing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Biotechnology Contract Manufacturing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale of Operation (Commercial Operations, Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Biotechnology Contract Manufacturing Market Insights, 2025
The biotechnology contract manufacturing market is growing robustly as biopharmaceutical companies outsource production to specialized contract manufacturing organizations (CMOs) to reduce costs and accelerate time-to-market. Recent trends include expanded single-use facility capabilities, modular manufacturing units, and flexible process platforms that accommodate diverse biologic modalities including mAbs, vaccines, and cell therapies. CMOs are investing in automation, digitalization, and advanced analytics to improve quality and compliance. Strategic partnerships and capacity expansions in emerging biotech hubs globally address rising demand. Regulatory requirements for quality assurance and supply chain integrity drive continuous process improvements. The market benefits from increasing complexity of biologic pipelines and the growing trend of biopharma virtual companies relying on outsourcing.
Five Trends Shaping the Global Biotechnology Contract Manufacturing Market in 2025 and Beyond
The global Biotechnology Contract Manufacturing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Biotechnology Contract Manufacturing Industry?
The Biotechnology Contract Manufacturing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Biotechnology Contract Manufacturing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Biotechnology Contract Manufacturing Market Segment Insights
The Biotechnology Contract Manufacturing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Others), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing), By Scale of Operation (Commercial Operations, Clinical Operations), By Source (Mammalian Expression Systems, Non-Mammalian Expression Systems), By Molecule (Monoclonal Antibodies, Cell Therapy & Gene Therapy, Antibody-Drug Conjugates (ADCs), Vaccines, Therapeutic Peptides & Proteins, Others), By Indication (Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Biotechnology Contract Manufacturing Industry Value Chain
The chapter identifies potential companies and their operations across the global Biotechnology Contract Manufacturing Industry ecosystem. It assists decision-makers in evaluating global Biotechnology Contract Manufacturing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Biotechnology Contract Manufacturing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Biotechnology Contract Manufacturing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Biotechnology Contract Manufacturing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Biotechnology Contract Manufacturing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Biotechnology Contract Manufacturing Market.
Europe Biotechnology Contract Manufacturing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Biotechnology Contract Manufacturing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Biotechnology Contract Manufacturing Industry competitiveness. The report analyses the key Biotechnology Contract Manufacturing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Biotechnology Contract Manufacturing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Biotechnology Contract Manufacturing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Biotechnology Contract Manufacturing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Biotechnology Contract Manufacturing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Biotechnology Contract Manufacturing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Biotechnology Contract Manufacturing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AbbVie Inc, AGC Inc, Boehringer Ingelheim International GmbH, Catalent Inc, Eurofins Scientific SE, FUJIFILM Holdings Corp, GenScript Biotech Corp, JSR Corp, Lonza Group Ltd, Merck KgaA, Samsung Biologics Co. Ltd, Thermo Fisher Scientific Inc, WuXi Biologics Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Biotechnology Contract Manufacturing Market Scope
Leading Segments
By Service
Manufacturing
Formulation and Fill-Finish
Packaging and Labeling
Others
By Type
Biologic Drug Substance Manufacturing
Biologic Drug Product Manufacturing
By Scale of Operation
Commercial Operations
Clinical Operations
By Source
Mammalian Expression Systems
Non-Mammalian Expression Systems
By Molecule
Monoclonal Antibodies
Cell Therapy & Gene Therapy
Antibody-Drug Conjugates (ADCs)
Vaccines
Therapeutic Peptides & Proteins
Others
By Indication
Oncology
Autoimmune Diseases
Cardiovascular Diseases
Metabolic Diseases
Infectious Diseases
Neurology
Others
Leading Companies
AbbVie Inc
AGC Inc
Boehringer Ingelheim International GmbH
Catalent Inc
Eurofins Scientific SE
FUJIFILM Holdings Corp
GenScript Biotech Corp
JSR Corp
Lonza Group Ltd
Merck KgaA
Samsung Biologics Co. Ltd
Thermo Fisher Scientific Inc
WuXi Biologics Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
186 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Biotechnology Contract Manufacturing Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Biotechnology Contract Manufacturing Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Biotechnology Contract Manufacturing Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Biotechnology Contract Manufacturing Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Biotechnology Contract Manufacturing Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Service
- Manufacturing
- Formulation and Fill-Finish
- Packaging and Labeling
- Others
- By Type
- Biologic Drug Substance Manufacturing
- Biologic Drug Product Manufacturing
- By Scale of Operation
- Commercial Operations
- Clinical Operations
- By Source
- Mammalian Expression Systems
- Non-Mammalian Expression Systems
- By Molecule
- Monoclonal Antibodies
- Cell Therapy & Gene Therapy
- Antibody-Drug Conjugates (ADCs)
- Vaccines
- Therapeutic Peptides & Proteins
- Others
- By Indication
- Oncology
- Autoimmune Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Infectious Diseases
- Neurology
- Others
- 6. Global Biotechnology Contract Manufacturing Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Biotechnology Contract Manufacturing Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Biotechnology Contract Manufacturing Market Trends and Growth Opportunities
- 6.2.1 North America Biotechnology Contract Manufacturing Market Outlook by Type
- 6.2.2 North America Biotechnology Contract Manufacturing Market Outlook by Application
- 6.3 North America Biotechnology Contract Manufacturing Market Outlook by Country
- 6.3.1 The US Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 6.3.2 Canada Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 6.3.3 Mexico Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 7. Europe Biotechnology Contract Manufacturing Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Biotechnology Contract Manufacturing Market Trends and Growth Opportunities
- 7.2.1 Europe Biotechnology Contract Manufacturing Market Outlook by Type
- 7.2.2 Europe Biotechnology Contract Manufacturing Market Outlook by Application
- 7.3 Europe Biotechnology Contract Manufacturing Market Outlook by Country
- 7.3.2 Germany Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 7.3.3 France Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 7.3.4 The UK Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 7.3.5 Spain Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 7.3.6 Italy Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 7.3.7 Russia Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 8. Asia Pacific Biotechnology Contract Manufacturing Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Biotechnology Contract Manufacturing Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Biotechnology Contract Manufacturing Market Outlook by Type
- 8.2.2 Asia Pacific Biotechnology Contract Manufacturing Market Outlook by Application
- 8.3 Asia Pacific Biotechnology Contract Manufacturing Market Outlook by Country
- 8.3.1 China Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 8.3.2 India Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 8.3.3 Japan Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 8.3.4 South Korea Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 8.3.5 Australia Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 8.3.6 South East Asia Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 9. South America Biotechnology Contract Manufacturing Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Biotechnology Contract Manufacturing Market Trends and Growth Opportunities
- 9.2.1 South America Biotechnology Contract Manufacturing Market Outlook by Type
- 9.2.2 South America Biotechnology Contract Manufacturing Market Outlook by Application
- 9.3 South America Biotechnology Contract Manufacturing Market Outlook by Country
- 9.3.1 Brazil Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 9.3.2 Argentina Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 10. Middle East and Africa Biotechnology Contract Manufacturing Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Biotechnology Contract Manufacturing Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Biotechnology Contract Manufacturing Market Outlook by Type
- 10.2.2 Middle East and Africa Biotechnology Contract Manufacturing Market Outlook by Application
- 10.3 Middle East and Africa Biotechnology Contract Manufacturing Market Outlook by Country
- 10.3.1 Saudi Arabia Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 10.3.2 The UAE Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 10.3.4 South Africa Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 10.3.5 Egypt Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Biotechnology Contract Manufacturing Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- AbbVie Inc
- AGC Inc
- Boehringer Ingelheim International GmbH
- Catalent Inc
- Eurofins Scientific SE
- FUJIFILM Holdings Corp
- GenScript Biotech Corp
- JSR Corp
- Lonza Group Ltd
- Merck KgaA
- Samsung Biologics Co. Ltd
- Thermo Fisher Scientific Inc
- WuXi Biologics Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
